Crossmark

Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions

Crossref DOI link: https://doi.org/10.1186/s13148-017-0437-0

Published Online: 2018-01-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mateu-Jimenez, Mercè

Curull, Víctor

Rodríguez-Fuster, Alberto

Aguiló, Rafael

Sánchez-Font, Albert

Pijuan, Lara

Gea, Joaquim

Barreiro, Esther
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (CIBER Enfermedades Respiratorias, FIS 11/02029 (FEDER), FIS 14/00713 (FEDER), PT13/0010/0005 (FEDER))

Sociedad Española de Neumología y Cirugía Torácica (SEPAR 2016)

Fundació Catalana de Pneumologia (FUCAP 2016)

Fondazione Internazionale Menarini (unrestricted grant from Menarini SA 2014)
More Information

Article History

Received: 25 July 2017

Accepted: 19 November 2017

First Online: 16 January 2018

Ethics approval and consent to participate

: Approval was obtained from the institutional Ethics Committee on Human Investigation (Hospital del Mar–IMIM, Barcelona, project number 2014/5776/1) in accordance with the World Medical Association guidelines (Helsinki Declaration of 2008) for research on human beings. Informed written consent was obtained from all patients at study entry and prior to initiation of therapies.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.